K-V Pharmaceutical Company (NYSE:KV.A)
About K-V Pharmaceutical Company (NYSE:KV.A) K-V Pharmaceutical Company (KV) is an integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products. It has offered a range of dosage form capabilities, including tablets, capsules, creams, liquids and ointments. It has historically operated in three segments: branded products, specialty generics and specialty raw materials. KV has conducted its branded pharmaceutical operations through its subsidiary, Ther-Rx Corporation, and its generic/non-branded pharmaceutical operations through ETHEX Corporation. Through Particle Dynamics, Inc., which KV has approved for divestiture, it has developed, manufactured and marketed value-added raw material products for the pharmaceutical industry and other markets. During fiscal year ended March 31, 2009, KV announced six separate